- Neuraxpharm launches its first products in the United Kingdom
- Craig Bowen appointed as General Manager of Neuraxpharm UK
July 31, 2019
Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the launch of its first products in the United Kingdom. Neuraxpharm also announces the appointment of new General Manager Craig Bowen, who will run Neuraxpharm UK Ltd., based in Reading (Berkshire, UK).